A

Anocca AB

78 employees

Anocca is a drug and immunotherapy developer aiming to uncover the therapeutic potential of T-cell immunity.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immunotherapeutics
Immunotechnology
Health Care
Immunology
Therapeutics
Immuno-Oncology
Drug Development
Drug Discovery

Date founded

2014

Funding rounds raised

Total raised

$37M

from 3 investors over 3 rounds

A

Anocca AB raised $37M on May 31, 2023

Investors: Mellby Gård and Swedbank Robur

A

Anocca AB raised $27M on December 21, 2022

Investors: European Investment Bank

FAQ